Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs

Detalhes bibliográficos
Autor(a) principal: Campos, Monique Paiva
Data de Publicação: 2018
Outros Autores: Figueiredo, Fabiano Borges, Morgado, Fernanda Nazaré, Renzetti, Alinne Rangel dos Santos, Souza, Sara Maria Marques de, Pereira, Sandro Antônio, Rodrigues-da-Silva, Rodrigo Nunes, Lima-Junior, Josué da Costa, Luca, Paula Mello de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/31525
Resumo: Inclui errata.
id CRUZ_f32223a86ca2eae938fa370bbb767b3e
oai_identifier_str oai:www.arca.fiocruz.br:icict/31525
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Campos, Monique PaivaFigueiredo, Fabiano BorgesMorgado, Fernanda NazaréRenzetti, Alinne Rangel dos SantosSouza, Sara Maria Marques dePereira, Sandro AntônioRodrigues-da-Silva, Rodrigo NunesLima-Junior, Josué da CostaLuca, Paula Mello de2019-02-11T11:01:35Z2019-02-11T11:01:35Z2018CAMPOS, Monique Paiva et al. Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs. Frontiers in Immunology, v. 9, p. 1-11, July 2018.1664-3224https://www.arca.fiocruz.br/handle/icict/3152510.3389/fimmu.2018.016901664-3224Inclui errata.Fundação Oswaldo Cruz. National Institute of Infectology Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. National Institute of Infectology Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa em Leishmanioses. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. National Institute of Infectology Evandro Chagas. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. National Institute of Infectology Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. National Institute of Infectology Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. National Institute of Infectology Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. National Institute of Infectology Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.In Brazil, canine visceral leishmaniasis (CVL) is caused by Leishmania infantum, presenting a broad spectrum of clinical manifestations. Dogs are the main parasite reservoir in urban areas and canine cases precede human infection. Currently, A2 protein-based Leish-Tec® vaccine is the only vaccine commercially available against CVL in Brazil. Considering that the main screening and confirmatory tests of canine infection are serological, it is possible that the antibody response elicited after vaccination interfere with diagnosis, leading to the inability to distinguish between vaccinated and infected animals. In order to identify the specific B-cell response induced after vaccination, A2 protein sequence was screened for main linear B-cell epitopes using in silico prediction (Bepipred) and immunological confirmation by enzyme-linked immunosorbent assay (ELISA). Three amino acid sequences were described as potential B-cell epitopes (PP16-SAEPHKAAVDV, SV11-PQSVGGPLSVGPQSVGP, and VQ34-VGPLSVGPQSVGPLSVGPLSVGPQAVGPLSVGPQ). Specific IgG ELISAs were performed in sera of 12 immunized dogs living in non-endemic areas, followed for up to 1 year after immunization. The results were compared with those obtained in a group of 10 symptomatic and 10 asymptomatic CVL dogs. All predicted epitopes were confirmed as linear B-cell epitopes broadly recognized by sera from studied dogs. Total IgG ELISAs demonstrated distinct patterns of response between peptides in the immunized and CVL groups. VQ34 peptide was recognized by the majority of sera from vaccinated and symptomatic dogs, and increases after vaccination. PP16 induced low levels of specific IgG that increased 1 year after immunization. Interestingly, a low frequency of reactivity was found against SV11 in naturally infected dogs (symptomatic and asymptomatic), while 83.3% of vaccinated dogs presented positive responses 1 year after immunization. The two animals in the vaccinated group that did not respond to SV11 1 year after immunization presented positive serology both 30 days and 6 months after immunization. In summary, we identified three main linear B-cell epitopes in A2-based vaccine. Moreover, the humoral response against SV11 presented marked differences between infected and Leish-Tec® vaccinated dogs and should be further investigated, in large trials, to confirm its potential as a serological marker able to distinguish between infected and vaccinated dogs.engFrontiers MediaLeishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleCanine visceral leishmaniasisVaccinesA2 proteinSerology testEpitope mappingEpitope predictioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/31525/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALve_Campos_Monique_etal_INI_2018.pdfve_Campos_Monique_etal_INI_2018.pdfapplication/pdf1724012https://www.arca.fiocruz.br/bitstream/icict/31525/2/ve_Campos_Monique_etal_INI_2018.pdf45e34c509447dd2b7b26bba89d2a1868MD52ERRATA_ve_Campos_Monique_etal_INI_2018.pdfERRATA_ve_Campos_Monique_etal_INI_2018.pdfapplication/pdf347665https://www.arca.fiocruz.br/bitstream/icict/31525/4/ERRATA_ve_Campos_Monique_etal_INI_2018.pdfbf01980ffac5c838f0532f0b0fcafceeMD54TEXTve_Campos_Monique_etal_INI_2018.pdf.txtve_Campos_Monique_etal_INI_2018.pdf.txtExtracted texttext/plain62048https://www.arca.fiocruz.br/bitstream/icict/31525/3/ve_Campos_Monique_etal_INI_2018.pdf.txt1361fc38334662306a7ae710a3088dd5MD53icict/315252023-02-28 22:43:38.784oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-01T01:43:38Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs
title Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs
spellingShingle Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs
Campos, Monique Paiva
Canine visceral leishmaniasis
Vaccines
A2 protein
Serology test
Epitope mapping
Epitope prediction
title_short Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs
title_full Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs
title_fullStr Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs
title_full_unstemmed Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs
title_sort Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs
author Campos, Monique Paiva
author_facet Campos, Monique Paiva
Figueiredo, Fabiano Borges
Morgado, Fernanda Nazaré
Renzetti, Alinne Rangel dos Santos
Souza, Sara Maria Marques de
Pereira, Sandro Antônio
Rodrigues-da-Silva, Rodrigo Nunes
Lima-Junior, Josué da Costa
Luca, Paula Mello de
author_role author
author2 Figueiredo, Fabiano Borges
Morgado, Fernanda Nazaré
Renzetti, Alinne Rangel dos Santos
Souza, Sara Maria Marques de
Pereira, Sandro Antônio
Rodrigues-da-Silva, Rodrigo Nunes
Lima-Junior, Josué da Costa
Luca, Paula Mello de
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Campos, Monique Paiva
Figueiredo, Fabiano Borges
Morgado, Fernanda Nazaré
Renzetti, Alinne Rangel dos Santos
Souza, Sara Maria Marques de
Pereira, Sandro Antônio
Rodrigues-da-Silva, Rodrigo Nunes
Lima-Junior, Josué da Costa
Luca, Paula Mello de
dc.subject.en.pt_BR.fl_str_mv Canine visceral leishmaniasis
Vaccines
A2 protein
Serology test
Epitope mapping
Epitope prediction
topic Canine visceral leishmaniasis
Vaccines
A2 protein
Serology test
Epitope mapping
Epitope prediction
description Inclui errata.
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2019-02-11T11:01:35Z
dc.date.available.fl_str_mv 2019-02-11T11:01:35Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv CAMPOS, Monique Paiva et al. Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs. Frontiers in Immunology, v. 9, p. 1-11, July 2018.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/31525
dc.identifier.issn.pt_BR.fl_str_mv 1664-3224
dc.identifier.doi.none.fl_str_mv 10.3389/fimmu.2018.01690
dc.identifier.eissn.none.fl_str_mv 1664-3224
identifier_str_mv CAMPOS, Monique Paiva et al. Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs. Frontiers in Immunology, v. 9, p. 1-11, July 2018.
1664-3224
10.3389/fimmu.2018.01690
url https://www.arca.fiocruz.br/handle/icict/31525
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/31525/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/31525/2/ve_Campos_Monique_etal_INI_2018.pdf
https://www.arca.fiocruz.br/bitstream/icict/31525/4/ERRATA_ve_Campos_Monique_etal_INI_2018.pdf
https://www.arca.fiocruz.br/bitstream/icict/31525/3/ve_Campos_Monique_etal_INI_2018.pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
45e34c509447dd2b7b26bba89d2a1868
bf01980ffac5c838f0532f0b0fcafcee
1361fc38334662306a7ae710a3088dd5
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324705921335296